Sun Pharma to buy Ranbaxy for $3.2 billion

Sun Pharmaceutical Industries Ltd said it will buy generic drug maker Ranbaxy Laboratories Ltd, which has hit regulatory snags in its key US market over quality issues, in an all-share deal with total equity value of $3.2 billion. Ranbaxy, India's No.1 ... Read Full Story